缺血性卒中或短暂性脑缺血发作的双重抗血小板治疗  

Dual antiplatelet therapy of ischemic stroke or transient ischemic attack

作　　者：李湘青[1] 徐福平[1] 董瑞剑[1] 于宗明[1] 汤克仁[1] 

机构地区：[1]淄博市中心医院神经内科,255036

出　　处：《国际脑血管病杂志》2014年第8期614-619,共6页International Journal of Cerebrovascular Diseases

摘　　要：2013年美国心脏协会／美国卒中协会颁布的缺血性卒中早期处理指南推荐单用阿司匹林进行抗血小板治疗，并未推荐其他抗血小板药，更未推荐联合应用多种抗血小板药。然而，2013年之后发表的大量文献显示，双重抗血小板药在防治缺血性卒中和短暂性脑缺血发作方面优于单个抗血小板药，并评估了双重抗血小板药治疗的安全性。The guidelines for the early management of patients with ischemic stroke from the American Heart Association/American Stroke Association in 2013 recommend antiplatelet therapy with aspirin alone, but did not recommend other antiplatelet agents and the combination of a variety of antiplatelet drugs. However, since 2013, a great deal of published literature has shown that dual antiplatelet agents are superior to single antiplatelet agent in the prevention and treatment of ischemic stroke and transient ischemic attack. In addition, they evaluated the safety of the treatment of dual antiplatelet therapy.

关 键 词：卒中 脑缺血 抗血小板聚集药 阿司匹林 氯吡格雷 药物疗法 联合 复发 

分 类 号：R743.3[医药卫生—神经病学与精神病学]